HealthStream (NASDAQ:HSTM) Stock Passes Above 200 Day Moving Average – What’s Next?

HealthStream, Inc. (NASDAQ:HSTM) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $22.41 and traded as high as $26.19. HealthStream shares last traded at $26.00, with a volume of 193,690 shares.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HSTM. Weiss Ratings upgraded HealthStream from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, June 3rd. Canaccord Genuity Group boosted their price objective on HealthStream to $24.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Finally, Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $24.00.

HealthStream Stock Performance

The firm’s 50 day simple moving average is $22.80 and its 200-day simple moving average is $22.43. The company has a market capitalization of $766.15 million, a price-to-earnings ratio of 39.13, a P/E/G ratio of 2.98 and a beta of 0.47.

HealthStream (NASDAQ:HSTM) last announced its earnings results on Monday, May 4th. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. HealthStream had a net margin of 6.39% and a return on equity of 6.47%. The company had revenue of $81.20 million for the quarter, compared to the consensus estimate of $79.68 million. As a group, equities analysts anticipate that HealthStream, Inc. will post 0.74 earnings per share for the current fiscal year.

HealthStream Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Monday, May 18th were issued a $0.035 dividend. The ex-dividend date was Monday, May 18th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.5%. HealthStream’s dividend payout ratio is currently 20.90%.

HealthStream declared that its Board of Directors has authorized a share repurchase plan on Friday, March 13th that allows the company to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the technology company to reacquire up to 1.7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Insiders Place Their Bets

In other news, Director Linda Rebrovick sold 2,000 shares of the company’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $25.00, for a total value of $50,000.00. Following the transaction, the director directly owned 54,181 shares of the company’s stock, valued at approximately $1,354,525. This represents a 3.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Kevin P. O’hara sold 3,000 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $24.08, for a total transaction of $72,240.00. Following the completion of the transaction, the executive vice president directly owned 20,982 shares in the company, valued at $505,246.56. This trade represents a 12.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 20.40% of the company’s stock.

Hedge Funds Weigh In On HealthStream

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its holdings in HealthStream by 6.4% during the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after purchasing an additional 87,177 shares during the last quarter. Copeland Capital Management LLC grew its holdings in HealthStream by 43.8% during the first quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares during the last quarter. Renaissance Technologies LLC grew its holdings in HealthStream by 0.5% during the first quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock valued at $9,896,000 after purchasing an additional 2,380 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in HealthStream by 4.6% during the fourth quarter. JPMorgan Chase & Co. now owns 452,897 shares of the technology company’s stock valued at $10,448,000 after purchasing an additional 20,075 shares during the last quarter. Finally, First Eagle Investment Management LLC grew its holdings in HealthStream by 1.1% during the fourth quarter. First Eagle Investment Management LLC now owns 413,698 shares of the technology company’s stock valued at $9,544,000 after purchasing an additional 4,300 shares during the last quarter. Institutional investors and hedge funds own 69.58% of the company’s stock.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.